WHO ICTRP trial
Accelerator-based BNCT for head and neck carcinoma
CTIS2024-515036-71-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-515036-71-00 |
|---|---|
| Public title | Accelerator-based BNCT for head and neck carcinoma |
| Scientific title | - HN-BNCT-01-2024 |
| Primary sponsor | HUS-Yhtymae |
| Secondary sponsors | Neutron Therapeutics Finland Oy |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Finland |
| Conditions | Head and neck carcinoma;Therapeutic area: Diseases [C] - Pathological Conditions, Signs and Symptoms [C23] |
| Registration date | Jul 26, 2024 |
| Target size | 10 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: